| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Klein Roger M. | 10% | $810,110 | 163,000 | Klein Roger M. | 04 Nov 2025 | |||
| LYTTON LAURENCE W | 3.9% | $158,087 | 61,274 | Lytton, Laurence W. | 31 Mar 2025 | |||
| MORGAN STANLEY | 0% | -95% | $331 | -$1,749,814 | 31 | -100% | Morgan Stanley | 30 Nov 2025 |
As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK). This represents 0% of the company’s total 1,552,381 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 0 | $0 | -$2,867,724 | $10.80 | 0 |
| 2025 Q3 | 590,713 | $2,937,342 | +$1,814,237 | $4.97 | 15 |
| 2025 Q2 | 232,022 | $603,642 | -$26,836 | $2.60 | 10 |
| 2025 Q1 | 242,206 | $666,068 | +$63,212 | $2.75 | 9 |
| 2024 Q4 | 218,456 | $965,575 | +$13,288 | $4.42 | 8 |
| 2024 Q3 | 208,317 | $994,552 | +$993,971 | $4.76 | 11 |